Loading stock…

Sigma Healthcare Limited (SIG) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Sigma Healthcare Limited

SIGMarket cap $21BPrice $1.8

Country🇦🇺Australia

SectorHealthcare

IndustryHealthcare Services

Distributes pharmaceuticals and medical products across Australia, supplying thousands of pharmacies nationwide. Recently merged with Chemist Warehouse, creating a retail pharmacy giant that now controls a massive slice of the country's script and front-of-store sales.

In Bastion Portfolios?

52W Return-6%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+54%10

Revenue Forecast

Rev CAGR (1y)+14%7

Rev CAGR (3y)+10%7

Rev CAGR (5y)+10%8

Earnings Forecast

EPS Growth Y+1+23%8

EPS Growth Y+2+17%8

EPS Growth Y+3+15%7

Quality

Margins

EBIT Margin9%4

Net Income Margin7%4

Free Cash Flow Margin5%4

Debt

Net Debt/EBITDA1.85

Efficiency

ROE15%6

ROA8%8

Earnings Stability44

GEAR+STRONG70

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)352

P/E Ratio (Forward 3y)262

P/BV6.03

EV Multiples

EV/EBITDA Fwd242

EV/EBIT Fwd253

Yield

Free Cash Flow Yield1.7%4

Dividend Yieldna–

Momentum

Short term

1 month return-2%7

3 month return-6%4

YTD return-9%3

Mid term

Price vs 52wHigh83%6

1 year return-8%4

Long term

3 year return+314%10

5 year return+407%10

Risk Shield

Price Risk

Beta0.110

Volatility24%9

Free Cash Flow

Free Cash Flow Margin5%4

Free Cash Flow Yield1.7%4

Quality

ROCE15%7

Earnings Stability44

Net Debt/EBITDA1.85

02Growth

Is it actually growing, and how fast?

SIGSigma Healthcare

Revenue FY26$7.5B

GROWTH RATING↗

STRONG76 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+54%10

Revenue, next 1Y+14%7

Revenue, next 3Y, CAGR+10%7

Revenue, next 5Y, CAGR+10%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+23%8

EPS growth, FY28E+17%8

EPS growth, FY29E+15%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 76% of companies worldwide.

Revenue grew 54%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 10%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 10%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 17%/yr vs revenue 10%/yr), so margins should widen.

WATCH

Revenue grew 54%/yr over the last 3 years; forecasts see it cooling to 10%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

SIGSigma Healthcare

Total return Current248%

Price return Current167%

MOMENTUM RATING↗

STRONG69 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-6%4

YTD return-9%3

MID & LONG-TERM▾SCORE

% of 52-week high83%6

1-year return-8%4

3-year return+314%10

5-year return+407%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +314% over three years and +407% over five, ahead of 90% of the market.

Strong recent results. The stock is outperforming over the past month (-2%).

WATCH

It's down 8% over the past year, now 17% below its 52-week high. That is right in line with the market.

Returns sit at the market level over three months (-6%).

WEAKNESSES

The stock is underperforming so far this year (-9%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming so far this year.

04Value

Are you paying a fair price for it?

Stop guessing on Sigma Healthcare Limited. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

SIGSigma Healthcare

Revenue FY26$7.5B

GROWTH RATING↗

STRONG76 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+54%10

Revenue, next 1Y+14%7

Revenue, next 3Y, CAGR+10%7

Revenue, next 5Y, CAGR+10%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+23%8

EPS growth, FY28E+17%8

EPS growth, FY29E+15%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 76% of companies worldwide.

Revenue grew 54%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 10%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 10%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 17%/yr vs revenue 10%/yr), so margins should widen.

WATCH

Revenue grew 54%/yr over the last 3 years; forecasts see it cooling to 10%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

SIGSigma Healthcare

Total return Current248%

Price return Current167%

MOMENTUM RATING↗

STRONG69 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-6%4

YTD return-9%3

MID & LONG-TERM▾SCORE

% of 52-week high83%6

1-year return-8%4

3-year return+314%10

5-year return+407%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +314% over three years and +407% over five, ahead of 90% of the market.

Strong recent results. The stock is outperforming over the past month (-2%).

WATCH

It's down 8% over the past year, now 17% below its 52-week high. That is right in line with the market.

Returns sit at the market level over three months (-6%).

WEAKNESSES

The stock is underperforming so far this year (-9%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming so far this year.

04Value

Are you paying a fair price for it?

Stop guessing on Sigma Healthcare Limited. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community